1997•Journal of Paediatrics and Child HealthRequires access

Preliminary study of glycopyrrolate in the management of drooling

LM Stern

Abstract

OBJECTIVE: A study was undertaken to assess the efficacy of an oral anticholinergic drug, glycopyrrolate, in the management of drooling in children and young adults with disabilities. METHODOLOGY: Glycopyrrolate was used by 24 children and young adults for up to 28 months. Parents/carers were asked to complete a questionnaire on the effects of the drug on severity and frequency of drooling and to report any side-effects. RESULTS: Twenty-two questionnaires were returned. There was a statistically significant decrease in both severity and frequency of drooling with minimal side-effects reported. CONCLUSION: In this preliminary study, glycopyrrolate was found to be an effective and well-tolerated addition to the management of drooling in children with disabilities.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 59 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Drooling, Glycopyrrolate, Medicine, Anticholinergic, Sialorrhea, Hypersalivation, Anesthesia, Pediatrics